Skip to content
Latest:
  • Psychedelics Could Help with Mental Health
  • Why CBD Stocks Could See Higher Highs
  • Psychedelic Stocks to Watch in New Year 2021
  • Electric Vehicle Market is Accelerating
  • Why Gene Editing Stocks Could be Hot in 2021
Research Driven News

Research Driven News

Stock Market News and Company Announcements

RSS CEO Comments

  • Coca-Cola will enter U.S. hard seltzer market in first half of 2021, CEO says
  • Addressing mental health is critical to getting Americans back to work, Sage Therapeutics CEO says

  • Home
  • Markets
    • Global Trade
    • Companies
    • Entrepreneurship
  • Biotech Stocks
  • Precious Metals
  • Cannabis Stocks
  • Tech Stocks

US FDA

Biotech Stocks Features Latest News 

Why Gene Editing Stocks Could be Hot in 2021

December 28, 2020December 28, 2020 Desiree Justice Ark Investment Management, DNA, Editas Medicine, gene editing, gene editing stocks, US FDA

Gene editing stocks are skyrocketing. While it’s not clear why, it may be thanks in part to Ark Investment Management

Read more

Recent Posts

  • Psychedelics Could Help with Mental Health
  • Why CBD Stocks Could See Higher Highs
  • Psychedelic Stocks to Watch in New Year 2021
  • Electric Vehicle Market is Accelerating
  • Why Gene Editing Stocks Could be Hot in 2021

Archives

  • January 2021
  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • December 2019
  • December 2017

Categories

  • Biotech Stocks
  • Companies
  • Corporate
  • Employment
  • Energy Stocks
  • Entrepreneurship
  • Environment
  • Features
  • Financial Stocks
  • Global Trade
  • Health
  • Investments
  • Latest News
  • Market
  • Money
  • News
  • Popular News
  • Recent News
  • Trending News
  • Privacy Policy
  • Disclaimer
Copyright © 2020 Research Driven News.
All rights reserved.
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057
  • Share on Reddit
  • Share on WhatsApp
  • Share on Twitter
  • Share on Facebook
  • Share on Email